My blog has moved!

You should be automatically redirected in 6 seconds. If not, visit
and update your bookmarks.

Saturday, February 9, 2008

Clinical Study of Deep Brain stimulation for Depression


St. Jude Medical Inc. (STJ) has garnered Food and Drug Administration approval to launch a trial the company plans to use to pursue U.S. approval for a pacemaker-like device that uses electricity to treat severe depression.

Or on
St. Jude Medical, Inc. Investor Relations Angela Craig, 651-481-7789 or Media Relations Kathleen Janasz, 651-415-7042 or St. Jude Medical, ANS Division Media Relations Denise Landry, 972-309-8085 St. Jude Medical, Inc. (NYSE:STJ) today announced it has received an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to begin enrollment in a controlled, multi-site, blinded, clinical study

Can someone explain to me why money is involved so explicitly?

Related posts on this blog:
The switch that lifts depression
6 Different locations for deep brain stimulation in depression

No comments: